These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6109966)

  • 1. Oestrogen containing oral contraceptives, decreased prostacyclin production, and haemolytic uraemic syndrome.
    Hauglustaine D; Vanrenterghem Y; Michielsen OP; van Damme B
    Lancet; 1981 Feb; 1(8215):328-9. PubMed ID: 6109966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent hemolytic uremic syndrome during oral contraception.
    Hauglustaine D; Van Damme B; Vanrenterghem Y; Michielsen P
    Clin Nephrol; 1981 Mar; 15(3):148-53. PubMed ID: 6168423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen containing oral contraceptives decrease prostacyclin production.
    Ylikorkala O; Puolakka J; Viinikka L
    Lancet; 1981 Jan; 1(8210):42. PubMed ID: 6109074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives.
    Maclennan AH
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral contraception: failures and risks].
    Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
    Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oestrogen containing oral contraceptives decrease prostacyclin production (author's transl)].
    Ylikorkala O; Puolakka J; Vinnikka L
    Contracept Fertil Sex (Paris); 1981 Sep; 9(9):547-9. PubMed ID: 12337641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign breast tumor and estrogenic hormones: a population-based retrospective study.
    Nomura A; Comstock GW
    Am J Epidemiol; 1976 May; 103(5):439-44. PubMed ID: 179318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemolytic-uremic syndrome in a young woman following the use of ovulation inhibitors].
    Blumberg A; Studer U; Briner J
    Schweiz Med Wochenschr; 1975 Oct; 105(41):1324-7. PubMed ID: 1215910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and ascorbic acid.
    Rivers JM
    Am J Clin Nutr; 1975 May; 28(5):550-4. PubMed ID: 1093379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological and histochemical changes in the cervix uteri under contraceptive pills.
    El Hakim SM; Abdin FH; Kandil O
    Egypt Popul Fam Plann Rev; 1976 Dec; 10(2):20-33. PubMed ID: 12308408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipid studies in women using combination type of oral contraceptives.
    Vaidya R; Purandare VN; Nain S; Gupta K; Rajwade N; Sheth UK
    J Obstet Gynaecol India; 1979 Jun; 29(3):644-6. PubMed ID: 12335922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of oral contraceptives on the metabolism of methaqualone in man.
    Oram M; Wilson K; Burnett D
    Br J Clin Pharmacol; 1982 Sep; 14(3):341-5. PubMed ID: 7126411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hypertension with irreversible renal failure due to oral contraceptives.
    Zech P; Rifle G; Lindner A; Sassard J; Blanc-Brunat N; Traeger J
    Br Med J; 1975 Nov; 4(5992):326-7. PubMed ID: 1192051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.